<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: therapeutic agents</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Compound that could prevent acute blood cancer relapse identified</title>
   	 <description>Researchers from the RIKEN Center for Integrative Medical Sciences in Japan report today that they have identified a compound that could be used as a new treatment to prevent relapse in acute myeloid leukemia patients.</description>
     <link>http://medicalxpress.com/news/2013-04-compound-acute-blood-cancer-relapse.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 17 Apr 2013 14:00:06 EST</pubDate>
	 <guid isPermaLink="false">news285423111</guid>
	 
</item>
<item>
     <title>Peptides for the treatment of severe diseases</title>
   	 <description>A new class of drugs for the treatment of severe diseases such as cancer and autoimmune diseases is developed by the start-up Bicycle Therapeutics. The company is generating bicyclic peptides that can selectively bind disease-related proteins and to modulate their function without affecting other proteins in the body.</description>
     <link>http://medicalxpress.com/news/2013-04-peptides-treatment-severe-diseases.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 15 Apr 2013 07:30:01 EST</pubDate>
	 <guid isPermaLink="false">news285229035</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/peptidesfort.jpg" width="90" height="90" />
</item>
<item>
     <title>Novel intercellular transportation system may have potential for delivering RNAi and other gene-based therapeutics</title>
   	 <description>(Medical Xpress)—Important new research from UMass Medical School demonstrates how exosomes shuttle proteins from neurons to muscle cells where they take part in critical signaling mechanisms, an exciting discovery that means these tiny vehicles could one day be loaded with therapeutic agents, such as RNA interference (RNAi), and directly target disease-carrying cells. The study, published this month in the journal Neuron, is the first evidence that exosomes can transfer membrane proteins that play an important role in cell-to-cell signaling in the nervous system.</description>
     <link>http://medicalxpress.com/news/2013-03-intercellular-potential-rnai-gene-based-therapeutics.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 27 Mar 2013 10:10:01 EST</pubDate>
	 <guid isPermaLink="false">news283596137</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/novelinterce.jpg" width="90" height="90" />
</item>
<item>
     <title>Aristolochic acid nephropathy, a global health problem</title>
   	 <description>(HealthDay)—Although the first description of a rapidly progressive nephropathy associated with the consumption of aristolochic acid (AA) found in Chinese herbs was first reported 20 years ago, AA-induced nephropathy remains a worldwide health concern due to the lack of regulation on herbal medication and the easy availability of such medications online, according to a review published in the March 19 issue of the Annals of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2013-03-aristolochic-acid-nephropathy-global-health.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 19 Mar 2013 13:20:01 EST</pubDate>
	 <guid isPermaLink="false">news282914874</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/aristolochic.jpg" width="90" height="90" />
</item>
<item>
     <title>Study points to essential role of IL-22 in lung repair after the flu</title>
   	 <description>Once the initial episode of influenza has passed, the chronic effects tend to be overlooked. The results of a new study indicate that the cytokine interleukin-22 (IL-22) plays a critical role in normal lung repair following influenza infection. This study is published in the April 2013 issue of the American Journal of Pathology.</description>
     <link>http://medicalxpress.com/news/2013-03-essential-role-il-lung-flu.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 11 Mar 2013 00:00:07 EST</pubDate>
	 <guid isPermaLink="false">news282138712</guid>
	 
</item>
<item>
     <title>EU releases 144 mn euro for new rare disease research</title>
   	 <description>The European Union on Thursday pledged 144 million euros of fresh funding for research on rare diseases that currently affect some 30 million Europeans, the majority of them children.</description>
     <link>http://medicalxpress.com/news/2013-02-eu-mn-euro-rare-disease.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 28 Feb 2013 04:50:01 EST</pubDate>
	 <guid isPermaLink="false">news281247852</guid>
	 
</item>
<item>
     <title>Propping open the door to the blood brain barrier</title>
   	 <description>The treatment of central nervous system (CNS) diseases can be particularly challenging because many of the therapeutic agents such as recombinant proteins and gene medicines are not easily transported across the blood-brain barrier (BBB). Focused ultrasound can be used to &quot;open the door&quot; of the blood brain barrier. However, finding a way to &quot;prop the door open&quot; to allow therapeutics to reach diseased tissue without damaging normal brain tissue is the focus of a new study by a team of researchers at the Institute of Biomedical Engineering at National Taiwan University presenting at the 57th Annual Meeting of the Biophysical Society (BPS), held Feb. 2-6, 2013, in Philadelphia, Pa.</description>
     <link>http://medicalxpress.com/news/2013-02-propping-door-blood-brain-barrier.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 01 Feb 2013 17:10:07 EST</pubDate>
	 <guid isPermaLink="false">news278959721</guid>
	 
</item>
<item>
     <title>Stem cells found to heal damaged artery in lab study</title>
   	 <description>Scientists at the Texas Biomedical Research Institute have for the first time demonstrated that baboon embryonic stem cells can be programmed to completely restore a severely damaged artery. These early results show promise for eventually developing stem cell therapies to restore human tissues or organs damaged by age or disease.</description>
     <link>http://medicalxpress.com/news/2013-01-stem-cells-artery-lab.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 10 Jan 2013 15:50:49 EST</pubDate>
	 <guid isPermaLink="false">news277055439</guid>
	 
</item>
<item>
     <title>Team mimicking a natural defense against malaria to develop new treatments</title>
   	 <description>(Medical Xpress)—One of the world's most devastating diseases is malaria, responsible for at least a million deaths annually, despite global efforts to combat it.  Researchers from the Perelman School of Medicine at the University of Pennsylvania, working with collaborators from Drexel University, The Children's Hospital of Philadelphia, and Johns Hopkins University, have identified a protein in human blood platelets that points to a powerful new weapon against the disease. Their work was published in this months' issue of Cell Host and Microbe.</description>
     <link>http://medicalxpress.com/news/2012-12-team-mimicking-natural-defense-malaria.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 27 Dec 2012 16:20:02 EST</pubDate>
	 <guid isPermaLink="false">news275845997</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/teammimickin.jpg" width="90" height="95" />
</item>
<item>
     <title>Researchers develop new drug delivery system for bladder cancer using nanoparticles</title>
   	 <description>A team of UC Davis scientists has shown in experimental mouse models that a new drug delivery system allows for administration of three times the maximum tolerated dose of a standard drug therapy for advanced bladder cancer, leading to more effective cancer control without increasing toxicity.</description>
     <link>http://medicalxpress.com/news/2012-10-drug-delivery-bladder-cancer-nanoparticles.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 25 Oct 2012 15:15:18 EST</pubDate>
	 <guid isPermaLink="false">news270396838</guid>
	 
</item>
<item>
     <title>USADA's chief science officer publishes editorial on anti-dope testing in sport: History and science</title>
   	 <description>Lance Armstrong's doping scandal may be considered by U.S. Anti-Doping Agency (USADA) as &quot;more extensive than any previously revealed in professional sports history,&quot; but a new editorial in The FASEB Journal by USADA's Larry D. Bowers shows that it is clearly not the first. From early athletes who used rat poison and heroin to fight fatigue to modern Olympians who perform under the ever-present shadow of high tech hormones, stimulants and steroids, this editorial lays out both the history and the science behind athletic &quot;doping&quot; scandals. Bowers traces modern antidoping regulation to tragic accidents such as the death of British cyclist Tommy Simpson in the 1967 Tour de France, a race then notorious as a pharmaceutical free-for-all.</description>
     <link>http://medicalxpress.com/news/2012-10-usada-chief-science-officer-publishes.html</link>
	 <category>Other</category>
	 <pubDate>Fri, 12 Oct 2012 16:58:48 EST</pubDate>
	 <guid isPermaLink="false">news269279907</guid>
	 
</item>
<item>
     <title>Mechanism of smoking-induced insulin resistance elucidated</title>
   	 <description>(HealthDay)—Smoking-induced insulin resistance, which improves with smoking cessation, may be due to activation of mammalian target of rapamycin (mTOR), according to a study published online Sept. 10 in Diabetes.</description>
     <link>http://medicalxpress.com/news/2012-09-mechanism-smoking-induced-insulin-resistance-elucidated.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 17 Sep 2012 12:51:35 EST</pubDate>
	 <guid isPermaLink="false">news267105084</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/mechanismofs.jpg" width="90" height="90" />
</item>
<item>
     <title>Joslin researchers gain new understanding of diabetes and kidney disease</title>
   	 <description>Scientists at Joslin Diabetes Center have identified biological mechanisms by which glucagon-like peptide-1 (GLP-1), a gut hormone, protects against kidney disease, and also mechanisms that inhibit its actions in diabetes. The findings, which are reported today online by Diabetes, may lead to the development of new therapeutic agents that harness the actions of GLP-1 to prevent the harmful effects of hyperglycemia on renal endothelial cells.</description>
     <link>http://medicalxpress.com/news/2012-07-joslin-gain-diabetes-kidney-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 23 Jul 2012 10:27:42 EST</pubDate>
	 <guid isPermaLink="false">news262258055</guid>
	 
</item>
<item>
     <title>Efficacy of herbal remedies for managing insomnia</title>
   	 <description>Approximately 1 in 3 Americans suffers from chronic sleep deprivation and another 10-15% of the population has chronic insomnia. Sleep disorders can profoundly affect a person's whole life and have been linked to a range of diseases, including obesity, depression, anxiety, and inflammatory disorders. Over-the-counter herbal remedies are often used to treat insomnia, but surprisingly, very little research has been done to study their efficacy, according to an article in Alternative and Complementary Therapies. </description>
     <link>http://medicalxpress.com/news/2012-07-efficacy-herbal-remedies-insomnia.html</link>
	 <category>Other</category>
	 <pubDate>Wed, 18 Jul 2012 12:20:29 EST</pubDate>
	 <guid isPermaLink="false">news261832822</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/efficacyofhe.jpg" width="90" height="90" />
</item>
<item>
     <title>Developing novel biomarkers to predict Alzheimer's disease</title>
   	 <description>Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer's disease months or even years before the first symptoms of the disease occur. The goal of the new collaboration between VTT and GE Healthcare is to validate this biomarker in a large patient cohort as well as to discover novel biomarker candidates.</description>
     <link>http://medicalxpress.com/news/2012-06-biomarkers-alzheimer-disease.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Tue, 26 Jun 2012 09:33:44 EST</pubDate>
	 <guid isPermaLink="false">news259922003</guid>
	 
</item>
<item>
     <title>Risks of mixing drugs and herbal supplements: What doctors and patients need to know</title>
   	 <description>Herbal, dietary, and energy or nutritional supplements may offer specific health benefits, but they can also have harmful and even life-threatening effects when combined with commonly used medications. Clinicians need to be aware of and educate their patients about the potential risks of mixing supplements and therapeutic agents, since their interaction can diminish or increase drug levels. This timely topic is explored in a provocative article in Alternative and Complementary Therapies, published by Mary Ann Liebert, Inc. The article is available free on the Alternative and Complementary Therapies website at www.liebertpub.com/act.</description>
     <link>http://medicalxpress.com/news/2012-05-drugs-herbal-supplements-doctors-patients.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 01 May 2012 11:10:02 EST</pubDate>
	 <guid isPermaLink="false">news255088498</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/risksofmixin.jpg" width="90" height="90" />
</item>
<item>
     <title>Study points to potential treatment for stroke</title>
   	 <description>Stanford University School of Medicine neuroscientists have demonstrated, in a study to be published online April 24 in Stroke, that a compound mimicking a key activity of a hefty, brain-based protein is capable of increasing the generation of new nerve cells, or neurons, in the brains of mice that have had strokes. The mice also exhibited a speedier recovery of their athletic ability.</description>
     <link>http://medicalxpress.com/news/2012-04-potential-treatment.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 24 Apr 2012 16:46:11 EST</pubDate>
	 <guid isPermaLink="false">news254504744</guid>
	 
</item>
<item>
     <title>Targeted therapeutics for colon cancer to be presented at AACR meeting</title>
   	 <description>Anurag Singh, PhD, assistant professor in the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine has been invited to present his recent work on targeted therapeutics for colon cancer at the American Association of Cancer Research Annual Meeting in Chicago, IL. Singh's seminar, scheduled for Tuesday April 3rd, will be featured in the &quot;Late-Breaking Abstracts Mini-Symposium&quot;. This highlights recent and provocative groundbreaking research in cancer biology.</description>
     <link>http://medicalxpress.com/news/2012-04-therapeutics-colon-cancer-aacr.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 04 Apr 2012 01:48:21 EST</pubDate>
	 <guid isPermaLink="false">news252722892</guid>
	 
</item>
<item>
     <title>Engineered bacteria effectively target tumors, enabling tumor imaging potential in mice</title>
   	 <description>Tumor-targeted bioluminescent bacteria have been shown for the first time to provide accurate 3D images of tumors in mice, further advancing the potential for targeted cancer drug delivery, according to a study published in the Jan. 25 issue of the online journal PLoS ONE.</description>
     <link>http://medicalxpress.com/news/2012-01-bacteria-effectively-tumors-enabling-tumor.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 25 Jan 2012 17:00:15 EST</pubDate>
	 <guid isPermaLink="false">news246710951</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/yt54433.jpg" width="90" height="90" />
</item>
<item>
     <title>Possible new pathway can overcome glioblastoma resistance</title>
   	 <description>Glioblastoma, a lethal brain cancer, is one of the most resistant to available therapies and patients typically live approximately 15 months.</description>
     <link>http://medicalxpress.com/news/2012-01-pathway-glioblastoma-resistance.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 24 Jan 2012 11:37:28 EST</pubDate>
	 <guid isPermaLink="false">news246627439</guid>
	 
</item>
<item>
     <title>Restoring blood flow</title>
   	 <description>Tissue deprived of oxygen (ischemia) is a serious health condition that can lead to damaged heart tissue following a heart attack and, in the case of peripheral arterial disease in limbs, amputation, particularly in diabetic patients.</description>
     <link>http://medicalxpress.com/news/2011-08-blood.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 01 Aug 2011 15:34:39 EST</pubDate>
	 <guid isPermaLink="false">news231431574</guid>
	 
</item>
<item>
     <title>Small molecules inhibit growth of human tumor cells</title>
   	 <description>Researchers from the Cancer Institute at NYU Langone Medical Center have identified three novel small molecules that interrupt a crucial cellular communication pathway that regulates many aspects of development and cancer. The finding, published in the April 12, 2011 issue of the Proceedings of the National Academy of Sciences and featured on its cover, could provide the basis for innovative therapies for colorectal cancer and other diseases associated with aberrations in this pathway.</description>
     <link>http://medicalxpress.com/news/2011-04-small-molecules-inhibit-growth-human.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 13 Apr 2011 08:49:01 EST</pubDate>
	 <guid isPermaLink="false">news221903318</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/smallmolecul.jpg" width="90" height="90" />
</item>


</channel>
</rss>
